Passive Transmission of COVID-19 Antibody From Mother to Infant
NCT ID: NCT05851911
Last Updated: 2023-07-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
300 participants
OBSERVATIONAL
2022-09-01
2024-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Investigation of the Passage of Antiviral Antibodies From Mother to Child
NCT05821764
Mother to Child Transmission of Antibody to Covid-19 The TRAB CoV-19 Study.
NCT05305261
Multisite Observational Maternal and Infant Study for COVID-19
NCT05031468
Efficacy and Safety of the Anti- COVID-19 Vaccin in Clinical Hematology Patients
NCT04852796
Immunity Against SARS-CoV2 in Children and Their Parents / COVID-19
NCT04355533
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group 1
Mother not vaccinated with COVID-19 vaccine
sars-cov-2 vaccine or infection
Whether to vaccinate COVID-19 vaccine, or infect with sars-cov-2
Control group 2
The mother was vaccinated with COVID-19 vaccine before pregnancy, and was not infected during pregnancy
sars-cov-2 vaccine or infection
Whether to vaccinate COVID-19 vaccine, or infect with sars-cov-2
Control group 3
The mother was vaccinated with COVID-19 vaccine before pregnancy, and was infected during pregnancy
sars-cov-2 vaccine or infection
Whether to vaccinate COVID-19 vaccine, or infect with sars-cov-2
Experimental group
The mother was not vaccinated with COVID-19 vaccine before pregnancy, so she was infected during pregnancy
sars-cov-2 vaccine or infection
Whether to vaccinate COVID-19 vaccine, or infect with sars-cov-2
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
sars-cov-2 vaccine or infection
Whether to vaccinate COVID-19 vaccine, or infect with sars-cov-2
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. No history of blood transfusion, chemotherapy, or related immunosuppressive therapy; No immune system related diseases;
Exclusion Criteria
0 Months
2 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Children's Hospital of Chongqing Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
yuting yang
researcher
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Yuting Yang
Chongqing, Chongqing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-380
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.